Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What I just posted is on Africa Business Page This Is The Real Deal. #WOW!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Record legal shipment nudges Africa towards $7bn cannabis market
4 min. read
Forbidden plant goes mainstream
South Africa is just the latest country to turn decisively in favour of a sector which has witnessed an astonishing transition from a global shadow industry to an agro-industrial powerhouse. From medical cannabis to lifestyle supplements and recreational smoking, cultural, medical and legal change is wafting the scent of the once forbidden plant firmly into the global mainstream.
By 2023, the value of Africa’s legal cannabis market could be at least $7.1bn across nine key African countries if they legalise recreational and medical use, according to The African Cannabis Report from industry analysts Prohibition Partners. Worldwide, the Covid-19 lockdown period saw record-breaking sales of cannabis in multiple regions. Global sales of CBD (an active cannabis ingredient frequently used as a natural remedy), medical cannabis, and adult-use (recreational) cannabis topped $37.4bn in 2021, and could rise to $102bn by 2026, says the firm.
I joined South Africa business news and everything is as it say. #WOW
Business
Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC (RSAMMDA.LLC) Completes Acquisition of Protext
June 13, 2022, 11:20 AM CDT
Share this article
Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC
(RSAMMDA.LLC) Completes Acquisition of Protext Mobility, Inc. (TXTM)
JOHANNESBURG, South Africa, June 13, 2022 (GLOBE NEWSWIRE) -- Republic of
South Africa Medical Marijuana Dispensaries Acquisitions LLC (“RSAMMDA.LLC”)
is pleased to announce it has closed on the acquisition of Protext Mobility,
Inc (OTC PINK: TXTM) (A.K.A. Protext Pharma) in a share exchange whereby 100%
of capital stock in RSAMMDA.LLC will be exchanged for Preferred Stock in
Protext. RSAMMDA.LLC. is a jointly owned company focused on acquistions with
two principals, Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”) who
represent the South African business entities of RSAMMD and Leeds Boerdery.
RSAMMD is a South African pioneer in the research, cultivation, production and
distribution of medical cannabis and cannabinoids. Leeds Boerdery, controlled
by Dr. J, owns the 5000 Hectacre New Castle Farm as well as federally issued
cannabis and hemp licenses issued by the Government of South Africa. RSAMMD
management have taken over the daily operations of Protext headed by Mr. Du
Plooy as CEO and Director, and Dr. Jamaloodeen as President and Chairman of
the Board.
Mr. Dylon Du Plooy, Protext CEO and Principal of RSAMMD.LLC, commented, “This
transaction has been a long time in the making. For the past couple years we
have been focused on building our operations in South Africa and globally,
where have built an extensive infrastructure and global cannabis/hemp
business. During this period of time, we have invested heavily in building a
significant cannabis/hemp operation to facilitate complete seed to sale, R&D,
global off-take agreements for end product as well as all the extraction
infrastructure needed to create what we believe to be some of the highest
quality hemp and cannabis on the planet. In South Africa right now, we have
just completed our semi-annual grow. RSAMMD in Joint Venture with Leeds
Boerdery, cultivated hemp and cannabis crops this past season on a combined
1000+ hectacres. All of this is done under federally issued permits and
licenses to grow, import/export hemp and cannabis, as well as research permits
for conducting testing of final products for human consumption and medicinal
benefits.”
Dr. Jamaloodeen, Protext President and Chairman, commented, “We are excited
about this transaction and taking Protext to the next level. We believe there
to be numerous synergies to incorporate the Protext proprietary live plant
extraction technology and processes into our existing infrastructure. We
envision adding other assets into the operations of Protext, including our
off-take agreements and present sales, with the goal of uplifting exchanges in
the future. As previously announced, Protext and RSAMMD jointly worked
together and conducted a series of tests on live cannabis to prove out that
the Kettle system and extraction technologies did what they were supposed to
do. We look forward to discussing this further as well as our upcoming
operational plans.”
“Over the coming days and weeks, we will be sharing our immediate term road
map and long-term plans we are developing for Protext which should translate
into increasing shareholder value. These plans include adding other valuable
assets to the company which complement the core business, and executing on
commercializing the proprietary live plant extraction technology as well as
deploying our crypto platform, with a TXTM token which we are excited to
rollout very soon,” concluded Mr. Du Plooy.
CONTACT INFORMATION
For all media inquiries or for further information, please contact
Dylon Du Plooy at: dylon@rsammd.co.za
Dr.J at: exportintl@aol.com
About RSAMMD
RSAMMD Acquisitions LLC is a jointly owned business of RSAMMD, a South African
pioneer in the research, cultivation, production and distribution of medical
cannabis and cannabinoids, and Dr. J, who operates the 5000 Hectacre New
Castle Farm as well as the federally issued cannabis and hemp licenses.
Together, we partner with leading hospitals and universities globally to
advance the clinical benefits and applications of cannabinoids.
RSAMMD’s founders are a group of medical doctors and pharmacists, and cannabis
activists who have been at the forefront of medical cannabis legislation and
South African cannabis legalization, which took place in September 2018. We
are committed to the advancement of technology and scientific research that
leads to an improved quality of life for patients around the world.
Please visit www.rsammd.co.za for further information.
About Protext (OTC PINK: TXTM)
Through previously disclosed acquisitions, Protext has engaged in the
research, testing and commercialization of highly bioavailable botanical
products all-natural ingredients formulated for nutraceutical and
pharmaceutical applications through the use of proprietary live plant
extraction technology.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current
expectations or beliefs, as well as a number of assumptions about future
events. Although we believe that the expectations reflected in the
forward-looking statements and the assumptions upon which they are based are
reasonable, we can give no assurance or guarantee that such expectations and
assumptions will prove to have been correct. Forward-looking statements are
generally identifiable by the use of words like "may," "will," "should,"
"could," "expect," "anticipate," "estimate," "believe," "intend," or "project"
or the negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue reliance on
these forward-looking statements, as these statements are subject to numerous
factors and uncertainties, including but not limited to: adverse economic
conditions, competition, adverse federal, state and local government
regulation, international governmental regulation, inadequate capital,
inability to carry out research, development and commercialization plans, loss
or retirement of key executives and other specific risks. To the extent that
statements in this press release are not strictly historical, including
statements as to revenue projections, business strategy, outlook, objectives,
future milestones, plans, intentions, goals, future financial conditions,
events conditioned on stockholder or other approval, or otherwise as to future
events, such statements are forward-looking, and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. The
forward-looking statements contained in this release are subject to certain
risks and uncertainties that could cause actual results to differ materially
from the statements made. The company disclaims any obligation to update
information contained in any forward-looking statement. This press release
shall not be deemed a general solicitation.
Captura de pantalla 2022-06-13 025004.png
Have a confidential tip for our reporters?
Get in touch
Before it's here, it's on the
Bloomberg Terminal
Learn more
by TaboolaSponsored LinksFrom The Web
We might have to start backing our money with Bitcoin sense it is worth more than Gold?
I see $3000 per share by this time next year if not before then just watch Christmas will be a day to remember just like Bitcoin.
I am going to Go buy me a I phone just so I can sign up and play
I see 0.05 real soon watch.
I signed up with coin champs platform to day.
People just hold on if you can it is coming.
Price target between $500 to $6000 dollars per share.
How high can this shell go up to you think and how high have you ever seen one go to.
All I can say is hold on we are going for a wild ride.
Are we being bought out or are we buying someone out I think it is (NRDY) also WOW.
Yes we are now !!!!!! PINK CURRENT!!!!!!!!!
The run has begun go Pbya and Ford Blue Ovial.????
We will be great after Sept 28 just hold on.
So high do you all think it will go by December. I think $25 dollars.
Let me say this, Major corporation's don't join in unless they know what's coming there way and believe me you these are the big boy and they are here to stay welcome to the fortune 500 school for major corporations.
Can you say $50 per share by December.
Let me say this, Major corporation's don't join in unless they know what's coming there way and believe me you these are the big boy and they are here to stay welcome to the fortune 500 school for major corporations.
Can you say $50 per share by December.
Do not be fooled PBYA is current but if they make you think they are not you will give away your shares for a little of nothing, play no games this is how the Big Boys play, do not get caught in the sitting middle in one of the big seats because they are watching they don't mind you being here just stay in your place and enjoy what they have done, I know I am the brother of a Big Boy.
Can you say $150 per share go (PBYA)
I WONDER IF IT WILL WOULD BE ON PREMARKET.
Adamis Pharmaceuticals Corporation (ADMP) They own the drug TEMPOL it was used for something else but it turned out it also work for covid 19.
Raymond James Says NIH Study Of Adamis Pharmaceuticals' TEMPOL Is 's a significant external validation of TEMPOL's potential to play a role in the treatment of COVID-19'
4:15 pm ET June 3, 2021 (Benzinga)
Elliot Wilbur
Raymond James[color=red][/color]
Can you see this batterie in cars and the back windows of cars are solo panels or the sunroof are solo panels it would go good in 18 wheelers or anything Electric needing a batterie WOW!
Go back and listen to News Nation they was talking about blockchain tonight on the news. NFT is selling on Blockchain. THEY ARE TALKING ABOUT BLOCKCHAIN and NFT!!!!!!
Do this batt really do what I see on the video, because if it do hot dam, I will be buying more can you say PPS $50 or more by the end of the year.
I bought some stock in the gray market before and glad I did.
THIS IS WHY CHINA INFECTION RATE IS SO LOW, I KNEW THEY HAD A BETTER MASK THAN US, IT WAS JUST A MATTER OF TIME BEFOR WE GOT THE MASK OVER HERE, I BEEN WAITING ON IT TO GET HERE.
Here is a little something I bet you did not know the new covid-19 Vaccine has Silver in it that's why silver is in high demand. (#Read this.!)
Medicine's growing silver use
Of all chemical elements, silver has the most powerful antibacterial action with the least toxicity to animal cells. Because like the other, more expensive precious metals, it interrupts the ability of bacteria cells to form certain chemical bonds essential to their survival. But cells in humans and other animals have thicker walls, and are so undisturbed.
When added to water, silver releases silver ions. These ions also kill and prevent biological growth, again disabling the metabolism of germs and hindering their membrane functions. The value of these properties has been known and used for centuries.
The Ancient Phoenicians, for instance, found they could keep water and other liquids fresh by storing them in silver-coated bottles. American pioneers 3,000 years later prevented dysentery, colds, and flu by putting silver dollars in milk bottles. Silver biocides are today found in hospital water systems, catheters, furniture and almost every tool in the operating theatre. Silver-copper ionisation has also been approved as a primary treatment for long-term control of legionella in air-cooling systems.
Silver nitrate was used in the late 1800s to cure new-born babies of certain eye infections, and doctors found that wounds healed faster with silver dressings. The metal was used in sutures for surgical wounds and to cure ulcers – a use which continues today, with silver-embedded bandages proven to be especially effective in healing the wounds of burn victims.
During the 1920s, over 3 million prescriptions per year were written in the US for medications containing silver. Due to the introduction of penicillin in the 1940s, antibiotics became the standard treatment for bacterial infections, and this use of silver diminished. But new scientific research has since allowed fresh expansion of the medical industry's use of silver.
Nanotechnology uses silver as an antimicrobial, reducing the metal to particles measured in billionths of a metre. This nanosilver acts as a catalyst for oxidation, generating oxygen from air or water which destroys the cell wall membranes of single-cell bacteria. Because it only "turns on" this reaction, it does not pollute the surrounding environment.
In sum, there is much more to silver than its historical use as a monetary metal, or its ongoing use in jewellery and investment. Industrial and technological use of silver accounts for well over half annual demand. That demand plays an important and changing part in helping set long-term price direction.
I am watching it live it is still going over 2 Billion.
They are the unmanned drone of the security world a powerful strike force.
you have know idea how huge this company is, can you say Amazon huge they will be in everybody's business doing security work all over the world.
(Welcome To The Future of Security)
I said it once and I will say it again they are the new head of the security industry, no more putting people life in danger in places you would not go. AITX will be there and every were else. I can hear them now saying, ( Hello AITX at your service how may we help you and keep you safe.) GO AITX!!!!!!!!!
Not able to right now coming soon just keep doing your DD and you will see Thank you for your concern.
To all those that do not know MNGG is owned and bought by BITCOIN they bought the shell it fits there profile perfectly. Just a little inside news for you all. (#IMO!?)
Steve Reinharz just text me the link to order the Hats and T-shirts and stuff this is the link. https://roboticassistancedevices.com/radarmy/
Have you all seen the t shirts and hats that go with this you can order. it is call Rad Army
Important Readup - $MINE DD: I just saw on the OTC markets website that the CEO of $MINE is Julius Makiri Jenge. So I did a search and found he is also the president and director of Transatlantic Capital Inc., which is also traded on the stock market under $TACI".
On 10/23/20 there was a press release with the following title: Transatlantic Capital Inc. Signs Land Deal for 250 Acres; To Grow Cannabis and Psilocybin Mushrooms in Jamaica.
Here is the link where you can see this (on the Wall Street Journal website): https://www.wsj.com/market-data/quotes/TACI/company-people/executive-profile/181850266
https://www.wsj.com/articles/transatlantic-capital-inc-signs-land-deal-for-250-acres-to-grow-cannabis-and-psilocybin-mushrooms-in-jamaica-01603455665?tesla=y
Connect the dots.